Shupeng Li Selected Research

carveol

1/2023	"Retraction notice to Carveol ameliorates mercury-induced oxidative stress, neuroinflammation, and neurodegeneration in a mouse brain" NeuroToxicology 92 (2022) 212-226.
8/2022	Neuroprotective Effect of Natural Compounds in Paclitaxel-Induced Chronic Inflammatory Pain.
1/2022	Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain.
1/2022	Carveol Promotes Nrf2 Contribution in Depressive Disorders through an Anti-inflammatory Mechanism.
1/2022	Carveol ameliorates mercury-induced oxidative stress, neuroinflammation, and neurodegeneration in a mouse brain.
1/2021	Carveol Attenuates Seizure Severity and Neuroinflammation in Pentylenetetrazole-Kindled Epileptic Rats by Regulating the Nrf2 Signaling Pathway.
1/2020	Potent Natural Antioxidant Carveol Attenuates MCAO-Stress Induced Oxidative, Neurodegeneration by Regulating the Nrf-2 Pathway.
1/2020	Carveol a Naturally-Derived Potent and Emerging Nrf2 Activator Protects Against Acetaminophen-Induced Hepatotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shupeng Li Research Topics

Disease

29	Neuroinflammatory Diseases 04/2024 - 01/2019
15	Neoplasms (Cancer) 12/2023 - 04/2017
11	Inflammation (Inflammations) 11/2023 - 01/2019
8	Ischemic Stroke 01/2022 - 01/2019
6	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 01/2019
6	Infarction (Infarctions) 01/2022 - 06/2013
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 06/2013
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2019
5	Brain Injuries (Brain Injury) 01/2020 - 01/2019
4	Pain (Aches) 11/2023 - 01/2021
4	Memory Disorders (Memory Loss) 04/2023 - 01/2020
4	Glioblastoma (Glioblastoma Multiforme) 09/2022 - 04/2017
4	Stroke (Strokes) 01/2022 - 01/2019
3	Nervous System Diseases (Neurological Disorders) 11/2023 - 01/2020
3	Glioma (Gliomas) 10/2023 - 04/2017
3	Depressive Disorder (Melancholia) 01/2023 - 01/2022
3	Hypoxia (Hypoxemia) 12/2021 - 01/2017
3	Cognitive Dysfunction 12/2021 - 01/2020
3	Brain Ischemia (Cerebral Ischemia) 01/2020 - 04/2012
3	Ischemia 01/2020 - 06/2013
2	Obesity 02/2024 - 05/2009
2	Wounds and Injuries (Trauma) 11/2023 - 01/2020
2	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 01/2020
2	Body Weight (Weight, Body) 09/2023 - 08/2022
2	Necrosis 09/2023 - 06/2022
2	Fibrosis (Cirrhosis) 08/2023 - 01/2021
2	Neuralgia (Stump Neuralgia) 08/2022 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 05/2009
2	Hyperalgesia 01/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 04/2021 - 01/2021
2	Schizophrenia (Dementia Praecox) 01/2018 - 12/2014
1	Urinary Tract Infections (Urinary Tract Infection) 04/2024
1	Pyelonephritis 04/2024
1	Anastomotic Leak 03/2024
1	Cystic Fibrosis (Mucoviscidosis) 02/2024
1	Respiratory Insufficiency (Respiratory Failure) 01/2024
1	Constipation 01/2024

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2014
10	AntioxidantsIBA 01/2022 - 01/2019
9	MelatoninIBA 04/2024 - 01/2019
9	Neuroprotective AgentsIBA 08/2022 - 01/2019
8	carveolIBA 01/2023 - 01/2020
6	LipopolysaccharidesIBA 01/2024 - 01/2020
6	Antidepressive Agents (Antidepressants)IBA 11/2023 - 01/2020
5	CytokinesIBA 04/2024 - 01/2021
5	Glutamic Acid (Glutamate)FDA Link 01/2024 - 01/2019
5	Dopamine (Intropin)FDA LinkGeneric 12/2023 - 11/2008
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 02/2021
4	EnzymesIBA 01/2022 - 01/2020
4	CalciumIBA 01/2020 - 01/2019
4	Oxygen (Dioxygen)IBA 01/2020 - 04/2012
4	Peptides (Polypeptides)IBA 01/2018 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
3	ibrutinibIBA 09/2023 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
3	Ethanol (Ethyl Alcohol)IBA 01/2022 - 01/2020
3	NF-kappa B (NF-kB)IBA 01/2022 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2019
2	Apolipoprotein E4IBA 04/2024 - 01/2019
2	LipidsIBA 02/2024 - 08/2023
2	Morphine (MS Contin)FDA LinkGeneric 01/2024 - 12/2023
2	MicellesIBA 12/2023 - 01/2020
2	Hyaluronic Acid (Hyaluronan)IBA 12/2023 - 01/2020
2	Glutamate Receptors (Glutamate Receptor)IBA 12/2023 - 06/2013
2	Dopamine Receptors (Dopamine Receptor)IBA 12/2023 - 01/2018
2	MercuryIBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 04/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 01/2020
2	5-MethoxypsoralenIBA 08/2022 - 01/2022
2	berbamine (penduline)IBA 08/2022 - 01/2022
2	carvacrolIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 01/2021
2	benzimidazoleIBA 01/2021 - 01/2020
2	acetamideIBA 01/2021 - 01/2020
2	OxadiazolesIBA 01/2021 - 01/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 01/2020
2	ImmunosorbentsIBA 01/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2017
2	N-Methylaspartate (NMDA)IBA 01/2019 - 01/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 12/2014
2	Glucose (Dextrose)FDA LinkGeneric 06/2013 - 04/2012
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 04/2024
1	AICA ribonucleotide (ZMP)IBA 04/2024
1	MetalsIBA 03/2024
1	HydrogelsIBA 03/2024
1	ChloridesIBA 02/2024
1	SolventsIBA 02/2024
1	GenisteinIBA 02/2024
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2024
1	Sulfur DioxideIBA 12/2023
1	monomethoxypolyethylene glycol (MPEG)IBA 12/2023

Therapy/Procedure

6	Therapeutics 12/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 01/2023 - 04/2021
3	Radiotherapy 01/2021 - 01/2015
2	Immunotherapy 01/2023 - 01/2021
1	Catheters 04/2024